Promising treatment to slow kidney disease doesn’t prove out in clinical trial
Progression of kidney disease in type 1 diabetes is correlated with increased amounts of uric acid. A drug that reduces uric acid levels was tested in a multi-institution randomized clinical trial. Though the study did not show the desired clinical benefit, it did provide a very clear answer to an important scientific question.
Read Original Article: Promising treatment to slow kidney disease doesn’t prove out in clinical trial »
